Q1 2017 Holdings
Filed 2017-05-15 | 24 holdings | $200.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $151.5M | 5,409,990 | 75.5% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $29.3M | 3,489,795 | 14.6% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $10.5M | 828,283 | 5.2% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $8.8M | 240,000 | 4.4% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $194.9K | 7,088,651 | 0.1% |
| Avexis Inc | COM | 05366U100 | $123.6K | 1,625,211 | 0.1% |
| Achillion Pharmaceuticals Inc(ACHNEUR) | COM | 00448Q201 | $57.4K | 13,633,220 | 0.0% |
| Aquinox Pharmaceuticals Inc | COM | 03842B101 | $36.2K | 2,184,047 | 0.0% |
| RA Pharmaceuticals Inc | COM | 74933V108 | $28.8K | 1,351,808 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $27.6K | 2,348,422 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $26.6K | 2,451,237 | 0.0% |
| Esperion Therapeutics Inc(ESPR) | COM | 29664W105 | $24.9K | 704,701 | 0.0% |
| Loxo Oncology Inc | COM | 548862101 | $12.6K | 298,935 | 0.0% |
| Acorda Therapeutics Inc | COM | 00484M106 | $10.3K | 489,828 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $9.1K | 532,426 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $9.0K | 1,820,138 | 0.0% |
| Ignyta Inc | COM | 451731103 | $8.8K | 1,025,291 | 0.0% |
| Calithera Biosciences Inc(CALAEUR) | COM | 13089P101 | $8.4K | 725,000 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $8.3K | 2,428,571 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $8.2K | 700,000 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $8.2K | 636,248 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $4.6K | 591,070 | 0.0% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $4.1K | 354,200 | 0.0% |
| Medicines Co | COM | 584688105 | $3.9K | 79,899 | 0.0% |